Who
Stephen J. Hoffman
Director
Company insider
Files Form 4 as: Director and 10% owner, Talphera; Director and 10% owner, Dicerna Pharmaceuticals; Chief Executive Officer, Whitehawk Therapeutics; Director, Genocea Biosciences; Chariman of the Board, Allos Therapeutics; Director, Sirtris Pharmaceuticals.
In numbers
- Trades disclosed
- 153
- Buys
- 7
- Sells
- 8
- Bought
- $19.0M
- Sold
- $2.5M
- Companies
- 6
- Companies where not an officer
- 4
- First trade
- 17 Feb 2006
- Last trade
- 22 Jun 2026
- Last filed
- 24 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Jun 2026filed 24 Jun 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Code A | —5,100 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,700 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,700 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Code A | —5,100 at $0.00 | filing |
| 23 Oct 2025filed 24 Oct 2025 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,600 at $0.00 | filing |
| 23 Oct 2025filed 24 Oct 2025 | TLPH TalpheraBiotechnology | SEC FORM 4 Code A | —4,267 at $0.00 | filing |
| 24 Jun 2024filed 24 Jun 2024 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,044 at $0.00 | filing |
| 24 Jun 2024filed 24 Jun 2024 | TLPH TalpheraBiotechnology | SEC FORM 4 Code A | —2,174 at $0.00 | filing |
| 10 Oct 2023filed 13 Dec 2023 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,487 at $0.00 | filing |
| 10 Oct 2023filed 13 Dec 2023 | TLPH TalpheraBiotechnology | SEC FORM 4 Code A | —581 at $0.00 | filing |
| 15 Jul 2022filed 15 Jul 2022 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,000 at $0.00 | filing |
| 15 Jul 2022filed 15 Jul 2022 | TLPH TalpheraBiotechnology | SEC FORM 4 Code A | —15,500 at $0.00 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —3,333 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —15,000 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —25,000 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —25,000 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —15,000 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —25,000 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —25,000 | filing |
| 28 Dec 2021filed 29 Dec 2021 | Dicerna Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —15,000 | filing |
News
Financial Review: Whitehawk Therapeutics (NASDAQ:WHWK) and BeyondSpring (NASDAQ:BYSI)WHWK · dailypolitical.com · 17 Oct 2026Evolus (NASDAQ:EOLS) & Talphera (NASDAQ:TLPH) Financial ComparisonTLPH · dailypolitical.com · 13 Oct 2026Head to Head Analysis: Whitehawk Therapeutics (NASDAQ:WHWK) vs. Surrozen (NASDAQ:SRZN)WHWK · dailypolitical.com · 10 Oct 2026
0 headlines in the last 90 days name Stephen J. Hoffman; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.